Instgra Tablet (Dolutegravir) – Second-Generation HIV Integrase Inhibitor
Instgra (Dolutegravir) is a prescription antiretroviral medication used in the treatment of HIV infection. As part of a combination antiretroviral therapy (cART) regimen, it suppresses HIV viral load to undetectable levels, protecting the immune system and significantly improving quality of life.
Composition: Dolutegravir (50mg)
Key Benefits:
- Reduces HIV viral load to undetectable levels
- Preserves and rebuilds CD4+ T-cell count (immune function)
- Dramatically lowers the risk of opportunistic infections
- Prevents progression to AIDS when taken consistently
Manufacturer: Cipla Ltd
Prescription-only antiretroviral. Must be taken as part of a complete HIV regimen under the guidance of an infectious disease specialist.
Composition Dolutegravir (50mg)
Dosage Form Tablets
Equivalent brand Tivicay
Generic Name Dolutegravir
Indication HIV infection
Manufacturer Emcure Pharmaceuticals Ltd
Packaging 30 tablets in 1 bottle
$96.00Price

